Australian TGA increases fees for all drug, device submissions by 5.6%
This article was originally published in Clinica
Executive Summary
The Australian Therapeutic Goods Administration has, as of 1 July, increased all its fees and charges by 5.6%. The increased fee will apply to drug and device submissions made in the financial year 2012-2013.